Standout Papers
Citation Impact
Citing Papers
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
Leukemia in twins: lessons in natural history
2003
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma
2004
Biology of Langerhans Cells and Langerhans Cell Histiocytosis
2006
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies
2008
Medulloblastomics: the end of the beginning
2012
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
2002
Germ-cell tumors in childhood and adolescence
2000
Features of the dendritic cell lineage
2010 StandoutNobel
Molecular subgroups of medulloblastoma
2012
Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
2009
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
The Molecular Signatures Database Hallmark Gene Set Collection
2015 Standout
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
2004
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
IgG4-Related Disease
2012 Standout
TH1 predominance is associated with improved survival in pediatric medulloblastoma patients
2011
Atypical Hemolytic–Uremic Syndrome
2009
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Medulloblastoma in childhood: new biological advances
2007
TEAD mediates YAP-dependent gene induction and growth control
2008 Standout
Children's Oncology Group's 2013 blueprint for research: Bone tumors
2012
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)
2000
Nonchannel drug targets in atrial fibrillation
2004
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
IgG4-related disease
2014 Standout
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
2009
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis
2002
Disseminated Intravascular Coagulation
1999 Standout
Clonal evolution in cancer
2012 StandoutNature
Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell–macrophage lineage
2010
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Circulating microparticles: pathophysiology and clinical implications
2006
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Purification of human von Willebrand factor–cleaving protease and its identification as a new member of the metalloproteinase family
2001
Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors
2003
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
TGF‐β signaling and the fibrotic response
2004 Standout
Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer
2007
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study
2000
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group
2010
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Annexins: From Structure to Function
2002 Standout
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome
2000
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
The Use of Soluble Fibrin in Evaluating the Acute and Chronic Hypercoagulable State
1999
The TITAN trial – Assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura
2012
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
2001
Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
2001
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
2001
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Works of U. Mittler being referenced
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the german prospective randomized trial hit ’91
2000
CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL)
2000
EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - Erste Ergebnisse
1999
p53 and ras Mutations in Ewing's Sarcoma
1998
Insulin-Like Growth Factor Binding Protein-2 at Diagnosis of Childhood Acute Lymphoblastic Leukemia and the Prediction of Relapse Risk
2005
Familial clustering of Langerhans cell histiocytosis
1999
BEP/VIP bei Kindern und Jugendlichen mit malignen nichttestikulären Keimzelltumoren
1993
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT‘91
2009
Genetic heterogeneity of severe von Willebrand disease type III in the German population
1994
Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
1996
Prognostic Relevance of Clinical and Biological Risk Factors in Childhood Medulloblastoma: Results of Patients Treated in the Prospective Multicenter Trial HIT'91
2007
Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia
2003
Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype.
1997
[Detection of soluble fibrin monomer complexes by the netropsin precipitation test in childhood meningitis].
1990